RG
SWAV icon

Renaissance Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Renaissance Group’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,156
Closed -$3.96M – 288
2024
Q1 		$3.96M Buy
12,156
+2,489
+26% +$611K 0.15% 114
2023
Q4 		$1.84M Buy
9,667
+263
+3% +$49.7K 0.08% 176
2023
Q3 		$1.87M Buy
9,404
+157
+2% +$37.1K 0.09% 166
2023
Q2 		$2.64M Buy
9,247
+493
+6% +$137K 0.11% 111
2023
Q1 		$1.9M Buy
8,754
+696
+9% +$136K 0.09% 132
2022
Q4 		$1.66M Buy
8,058
+142
+2% +$35.9K 0.08% 135
2022
Q3 		$2.2M Buy
7,916
+174
+2% +$44.2K 0.12% 110
2022
Q2 		$1.48M Buy
+7,742
New +$1.37M 0.08% 122

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $273M AUM 19.98% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Renaissance Group's SWAV Position: Q2 2024 in Review

Renaissance Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 12,156 shares — an estimated $3.96M sold.

Renaissance Group first reported a position in SWAV in Q2 2022 and held it in 8 quarters. The position peaked at $3.96M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Renaissance Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Renaissance Group sold 12,156 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $3.96M.
  • Renaissance Group first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
  • Renaissance Group's Shockwave Medical, Inc. Common Stock position peaked at $3.96M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Renaissance Group's 13F filing for Q2 2024, filed 14 Aug 2024.